Drugs / Human amniotic suspension allograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04698265 | Jan 2021 → Jan 2022 | osteoarthritis, knee | Kaohsiung Veterans General Hospital. | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human amniotic suspension allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04698265 ↗ |
| Known as | ASA | “Human amniotic suspension allograft (ASA) intra-articular injection.” NCT04698265 ↗ |
| Modality | Cell therapy | “Human amniotic suspension allograft (ASA) contains particulated human amniotic membrane and cells derived from the amniotic fluid.” NCT04698265 ↗ |
| Route | Other | “Human amniotic suspension allograft (ASA) intra-articular injection.” NCT04698265 ↗ |